Change in Colorectal Cancer Tests Submitted for Reimbursement in Switzerland 2012–2018: Evidence from Claims Data of a Large Insurance
Objectives: Guidelines recommend colorectal cancer (CRC) screening by fecal occult blood test (FOBT) or colonoscopy. In 2013, Switzerland introduced reimbursement of CRC screening by mandatory health insurance for 50-69-years-olds, after they met their deductible. We hypothesized that the 2013 reimb...
Guardado en:
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5902c84a04d44948a4b6ea3d015bf56a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:5902c84a04d44948a4b6ea3d015bf56a |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:5902c84a04d44948a4b6ea3d015bf56a2021-11-09T15:17:05ZChange in Colorectal Cancer Tests Submitted for Reimbursement in Switzerland 2012–2018: Evidence from Claims Data of a Large Insurance1661-856410.3389/ijph.2021.1604073https://doaj.org/article/5902c84a04d44948a4b6ea3d015bf56a2021-10-01T00:00:00Zhttps://www.ssph-journal.org/articles/10.3389/ijph.2021.1604073/fullhttps://doaj.org/toc/1661-8564Objectives: Guidelines recommend colorectal cancer (CRC) screening by fecal occult blood test (FOBT) or colonoscopy. In 2013, Switzerland introduced reimbursement of CRC screening by mandatory health insurance for 50-69-years-olds, after they met their deductible. We hypothesized that the 2013 reimbursement policy increased testing rate.Methods: In claims data from a Swiss insurance, we determined yearly CRC testing rate among 50-75-year-olds (2012–2018) and the association with socio-demographic, insurance-, and health-related covariates with multivariate-adjusted logistic regression models. We tested for interaction of age (50–69/70–75) on testing rate over time.Results: Among insurees (2012:355′683; 2018:348′526), yearly CRC testing rate increased from 2012 to 2018 (overall: 8.1–9.9%; colonoscopy: 5.0–7.6%; FOBT: 3.1–2.3%). Odds ratio (OR) were higher for 70–75-year-olds (2012: 1.16, 95%CI 1.13–1.20; 2018: 1.05, 95%CI 1.02–1.08). Deductible interacted with changes in testing rate over time (p < 0.001). The increase in testing rate was proportionally higher among 50-69-years-olds than 70-75-year-olds over the years.Conclusions: CRC testing rate in Switzerland increased from 2012 to 2018, particularly among 50-69-years-olds, the target population of the 2013 law. Future studies should explore the effect of encouraging FOBT or waiving deductible.Rémi SchneiderMarkus NäpflinLamprini SyrogiannouliSarah BissigKali TalJean-Luc BulliardCyril DucrosOliver SennKevin SelbyCaroline BählerEva BlozikReto AuerFrontiers Media S.A.articlecolorectal cancer screeningfecal occult blood testcolonoscopytesting ratesSwiss health insurancePublic aspects of medicineRA1-1270ENInternational Journal of Public Health, Vol 66 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
colorectal cancer screening fecal occult blood test colonoscopy testing rates Swiss health insurance Public aspects of medicine RA1-1270 |
spellingShingle |
colorectal cancer screening fecal occult blood test colonoscopy testing rates Swiss health insurance Public aspects of medicine RA1-1270 Rémi Schneider Markus Näpflin Lamprini Syrogiannouli Sarah Bissig Kali Tal Jean-Luc Bulliard Cyril Ducros Oliver Senn Kevin Selby Caroline Bähler Eva Blozik Reto Auer Change in Colorectal Cancer Tests Submitted for Reimbursement in Switzerland 2012–2018: Evidence from Claims Data of a Large Insurance |
description |
Objectives: Guidelines recommend colorectal cancer (CRC) screening by fecal occult blood test (FOBT) or colonoscopy. In 2013, Switzerland introduced reimbursement of CRC screening by mandatory health insurance for 50-69-years-olds, after they met their deductible. We hypothesized that the 2013 reimbursement policy increased testing rate.Methods: In claims data from a Swiss insurance, we determined yearly CRC testing rate among 50-75-year-olds (2012–2018) and the association with socio-demographic, insurance-, and health-related covariates with multivariate-adjusted logistic regression models. We tested for interaction of age (50–69/70–75) on testing rate over time.Results: Among insurees (2012:355′683; 2018:348′526), yearly CRC testing rate increased from 2012 to 2018 (overall: 8.1–9.9%; colonoscopy: 5.0–7.6%; FOBT: 3.1–2.3%). Odds ratio (OR) were higher for 70–75-year-olds (2012: 1.16, 95%CI 1.13–1.20; 2018: 1.05, 95%CI 1.02–1.08). Deductible interacted with changes in testing rate over time (p < 0.001). The increase in testing rate was proportionally higher among 50-69-years-olds than 70-75-year-olds over the years.Conclusions: CRC testing rate in Switzerland increased from 2012 to 2018, particularly among 50-69-years-olds, the target population of the 2013 law. Future studies should explore the effect of encouraging FOBT or waiving deductible. |
format |
article |
author |
Rémi Schneider Markus Näpflin Lamprini Syrogiannouli Sarah Bissig Kali Tal Jean-Luc Bulliard Cyril Ducros Oliver Senn Kevin Selby Caroline Bähler Eva Blozik Reto Auer |
author_facet |
Rémi Schneider Markus Näpflin Lamprini Syrogiannouli Sarah Bissig Kali Tal Jean-Luc Bulliard Cyril Ducros Oliver Senn Kevin Selby Caroline Bähler Eva Blozik Reto Auer |
author_sort |
Rémi Schneider |
title |
Change in Colorectal Cancer Tests Submitted for Reimbursement in Switzerland 2012–2018: Evidence from Claims Data of a Large Insurance |
title_short |
Change in Colorectal Cancer Tests Submitted for Reimbursement in Switzerland 2012–2018: Evidence from Claims Data of a Large Insurance |
title_full |
Change in Colorectal Cancer Tests Submitted for Reimbursement in Switzerland 2012–2018: Evidence from Claims Data of a Large Insurance |
title_fullStr |
Change in Colorectal Cancer Tests Submitted for Reimbursement in Switzerland 2012–2018: Evidence from Claims Data of a Large Insurance |
title_full_unstemmed |
Change in Colorectal Cancer Tests Submitted for Reimbursement in Switzerland 2012–2018: Evidence from Claims Data of a Large Insurance |
title_sort |
change in colorectal cancer tests submitted for reimbursement in switzerland 2012–2018: evidence from claims data of a large insurance |
publisher |
Frontiers Media S.A. |
publishDate |
2021 |
url |
https://doaj.org/article/5902c84a04d44948a4b6ea3d015bf56a |
work_keys_str_mv |
AT remischneider changeincolorectalcancertestssubmittedforreimbursementinswitzerland20122018evidencefromclaimsdataofalargeinsurance AT markusnapflin changeincolorectalcancertestssubmittedforreimbursementinswitzerland20122018evidencefromclaimsdataofalargeinsurance AT lamprinisyrogiannouli changeincolorectalcancertestssubmittedforreimbursementinswitzerland20122018evidencefromclaimsdataofalargeinsurance AT sarahbissig changeincolorectalcancertestssubmittedforreimbursementinswitzerland20122018evidencefromclaimsdataofalargeinsurance AT kalital changeincolorectalcancertestssubmittedforreimbursementinswitzerland20122018evidencefromclaimsdataofalargeinsurance AT jeanlucbulliard changeincolorectalcancertestssubmittedforreimbursementinswitzerland20122018evidencefromclaimsdataofalargeinsurance AT cyrilducros changeincolorectalcancertestssubmittedforreimbursementinswitzerland20122018evidencefromclaimsdataofalargeinsurance AT oliversenn changeincolorectalcancertestssubmittedforreimbursementinswitzerland20122018evidencefromclaimsdataofalargeinsurance AT kevinselby changeincolorectalcancertestssubmittedforreimbursementinswitzerland20122018evidencefromclaimsdataofalargeinsurance AT carolinebahler changeincolorectalcancertestssubmittedforreimbursementinswitzerland20122018evidencefromclaimsdataofalargeinsurance AT evablozik changeincolorectalcancertestssubmittedforreimbursementinswitzerland20122018evidencefromclaimsdataofalargeinsurance AT retoauer changeincolorectalcancertestssubmittedforreimbursementinswitzerland20122018evidencefromclaimsdataofalargeinsurance |
_version_ |
1718440930752593920 |